Cambridge, United Kingdom

Daniel Bolland

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The Babraham Institute. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Bolland

Introduction

Daniel Bolland is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the area of antigen receptor repertoires. His work is characterized by a commitment to advancing scientific understanding through innovative methods.

Latest Patents

Daniel Bolland holds a patent for a method of identifying VDJ recombination products. This invention relates to a method that utilizes sequence-specific enrichment and specific restriction endonuclease enzymes or other DNA-shearing approaches. The goal of this method is to provide high resolution and high throughput interrogation of antigen receptor repertoires. He has 1 patent to his name.

Career Highlights

Bolland is currently affiliated with the Babraham Institute, where he continues to engage in groundbreaking research. His work at the institute has positioned him as a key figure in the study of genetic recombination and its implications for immunology.

Collaborations

Throughout his career, Daniel has collaborated with esteemed colleagues such as Andrew Wood and Anne Corcoran. These partnerships have further enriched his research and contributed to the advancement of knowledge in his field.

Conclusion

Daniel Bolland's innovative work in identifying VDJ recombination products exemplifies the impact of dedicated research in biotechnology. His contributions continue to influence the scientific community and pave the way for future discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…